Christopher McNulty
2018
In 2018, Christopher McNulty earned a total compensation of $489.7K as Former Chief Financial Officer at InVivo Therapeutics Holdings, a 31% decrease compared to previous year.
Compensation breakdown
| Salary | $137,543 |
|---|---|
| Other | $352,130 |
| Total | $489,673 |
McNulty received $352.1K in other compensation, accounting for 72% of the total pay in 2018.
McNulty also received $137.5K in salary.
Rankings
In 2018, Christopher McNulty's compensation ranked 11,955th out of 14,244 executives tracked by ExecPay. In other words, McNulty earned more than 16.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,955 out of 14,244 | 16th |
Division Manufacturing | 4,845 out of 5,762 | 16th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 671 out of 849 | 21st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 425 out of 547 | 22nd |
Industry Surgical and Medical Instruments and Apparatus | 277 out of 348 | 20th |
Source: SEC filing on November 26, 2019.
McNulty's colleagues
We found two more compensation records of executives who worked with Christopher McNulty at InVivo Therapeutics Holdings in 2018.